NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
Back to search
Official data from USPTO
CETSABLE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CETSABLE
ST13
US500000079335884Class
1, 5, 42
Filing
79335884
Registration
7123403
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
11/23/2025
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/18/2021
Registration date
08/01/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2023
Last transaction
11/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SE
Examiner
SMITH,CYNTHIA RINALDI
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pelago Bioscience AB
Representatives
Sandra J. Lex Mendelsohn Dunleavy, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
biochemicals for in vitro and in vivo scientific use; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents for scientific use; tagged antibodies for scientific use; polymers for use in the analysis of proteins; reagents for scientific purposes; testing reagents for scientific use; universal reagents for automated test systems for laboratory use; universal reagents for automated test systems for scientific use; chemical substances for scientific use; enzymes for scientific purposes; enzymes for scientific and research purposes in detecting proteins; proteins for scientific and research purposes in detecting antibodies; proteins for use in science; protein in raw material form for scientific and research purposes; chemical substances for impregnation into membranes to separate proteins from liquids; enzymes for scientific and research purposes for measuring proteins; chemical substances for analysis in laboratoriesother than for medical or veterinary purposes
Class 5
Enzymes for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical use; chemical reagents for medical or veterinary purposes; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; reagents for analytical purposes for medical purposes; reagents for use in analysis for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents and media for medical and veterinary diagnostic purposes
Class 42
Services of a chemical and/or biological laboratory; research and development services in the field of chemistry; laboratory analysis in the field of chemistry; scientific laboratory services; biological laboratory services; testing of pharmaceuticals; analysis of human tissues for medical research; research on the subject of pharmaceuticals; research and development of vaccines and medicines; conducting early evaluations in the field of new pharmaceuticals; medical research; biological research; medical laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; scientific research and development; biochemical research and development; biochemical analysis; biochemistry research services; biological analysis; biomedical research services; chemical research and analysis services
Publications
History of USPTO decisions and trademark events.
31 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/27/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2023
FIMP
FINAL DISPOSITION PROCESSED
11/01/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/01/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/01/2023
DOCK
ASSIGNED TO EXAMINER
07/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/17/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2023
PUBO
PUBLISHED FOR OPPOSITION
05/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/26/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2023
ATRV
ATTORNEY REVIEW COMPLETED
01/09/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
10/07/2022
RFNT
REFUSAL PROCESSED BY IB
09/12/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/22/2022
RFRR
REFUSAL PROCESSED BY MPU
08/22/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/28/2022
CNRT
NON-FINAL ACTION WRITTEN
07/27/2022
DOCK
ASSIGNED TO EXAMINER
07/25/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/19/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/29/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/17/2022
Continuous trademark protection
Get notified about every new filing that threatens CETSABLE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.